Key result
Cathepsin B knockout or pharmacological inhibition attenuates pressure overload-induced cardiac hypertrophy and apoptosis via the TNF-α/ASK1/JNK signaling pathway in experimental models.
Why the study?
Does Cathepsin B inhibition prevent cardiac remodeling and hypertrophy in preclinical models of pressure overload?
Population
Preclinical models: mice subjected to transaortic constriction for up to 8 weeks, and H9c2 rat myoblastic…
Comparison
Cathepsin B knockout, shRNA knockdown, or… vs Wild-type (WT) littermates or control cells
Design
Editorial
Follow-up
up to 8 wk
Authors
Loading...
This editorial highlights preclinical evidence that cathepsin B plays a necessary role in pressure overload-induced cardiac remodeling and apoptosis via the TNF-α/ASK1/JNK pathway.
Does Cathepsin B inhibition prevent cardiac remodeling and hypertrophy in preclinical models of pressure overload?
This editorial highlights preclinical evidence that cathepsin B plays a necessary role in pressure overload-induced cardiac remodeling and apoptosis via the TNF-α/ASK1/JNK pathway.
Blondelle et al. (2015) conducted an editorial in Cardiac remodeling. Cathepsin B inhibition or knockout was evaluated. Cathepsin B knockout or pharmacological inhibition attenuates pressure overload-induced cardiac hypertrophy and apoptosis via the TNF-α/ASK1/JNK signaling pathway in experimental models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: